A Systematic Review of Venetoclax and Azacitidine: Effectiveness and Safety for Newly Diagnosed and Relapsed Acute Myeloid Leukemia Patients

被引：0
|
作者：
Ibrahim, Ahmed [1 ]
Yousaf, Muhammad Abdullah [1 ]
Anwar, Zain [2 ]
Anum [3 ]
Batool, Maha [1 ]
Rehman, Mohammad [1 ]
Safdar, Omar A. [4 ]
Khattak, Zeeshan Ahmed [5 ]
Faraz, Fatima [1 ]
Khalid, Huma [1 ]
机构：
[1] Rawalpindi Med Univ, Rawalpindi, Pakistan
[2] Univ Sch, Hunting Valley, OH USA
[3] Faisalabad Med Univ, Faisalabad, Pakistan
[4] Univ Arizona, Tucson, AZ USA
[5] Shifa Int Hosp Ltd, Islamabad, Pakistan
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187691
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study
    Alwadi, Mohammmad
    Howaidi, Jude
    Alrajhi, Abdullah M.
    Alnakhli, Adel
    Marei, Mohammed A.
    Tailor, Imran K.
    Alnajjar, Fouad H.
    Altaf, Syed Y.
    Alnoamani, Mohammed S.
    Alzahrani, Kamal
    Alshehri, Hassan
    Motabi, Ibraheem H.
    Zaidi, Syed Ziauddin A.
    Alshehry, Nawal F.
    Alfayez, Mansour
    BLOOD, 2021, 138
  • [22] A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia
    Murthy, Guru Subramanian Guru
    Saliba, Antoine N.
    Szabo, Aniko
    Harrington, Alexandra
    Abedin, Sameem
    Carlson, Karen
    Michaelis, Laura
    Runaas, Lyndsey
    Baim, Arielle
    Hinman, Alex
    Maldonado-Schmidt, Sonia
    Venkatachalam, Annapoorna
    Flatten, Karen S.
    Peterson, Kevin L.
    Schneider, Paula A.
    Litzow, Mark
    Kaufmann, Scott H.
    Atallah, Ehab
    HAEMATOLOGICA, 2024, 109 (09) : 2864 - 2872
  • [23] Phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in older patients with newly diagnosed acute myeloid leukemia
    Liu, Qingyang
    Yang, Jingjing
    Lv, Lei
    Zhang, Xiawei
    Li, Meng
    Xu, Lingmin
    Huang, Sai
    Jing, Yu
    Dou, Liping
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [24] COMPARISON OF AZACITIDINE AND DECITABINE FOR THE TREATMENT OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS
    Saiz-Rodriguez, M.
    Cuevas, B.
    Martinez-Cuadron, D.
    Campuzano, V
    Cuevas, M., V
    Hermida, G.
    Alvarez, R.
    Gonzalez-Lopez, T. J.
    Diaz-Galvez, F. J.
    De Vicente, P.
    Montesinos, P.
    Labrador, J.
    HAEMATOLOGICA, 2020, 105 : 56 - 57
  • [25] The impact of secondary-type mutations in newly diagnosed acute myeloid leukemia treated with venetoclax and decitabine or azacitidine
    Doyel, Michael
    Bouligny, Ian Michael
    Murray, Graeme
    Patel, Tilak
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Thuy Ho
    Zacholski, Kyle
    Venn, Chad Michael
    Alnimer, Yanal Mufeed
    Wages, Nolan
    Grant, Steven
    Maher, Keri Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Cost-Utility Analysis
    Guinan, Kimberly
    Mathurin, Karine
    Au, Yunghan
    Schuh, Andre C.
    Bui, Cat N.
    Chai, Xinglei
    Lachaine, Jean
    CURRENT ONCOLOGY, 2022, 29 (10) : 7524 - 7536
  • [27] Hypomethylating Agent and Venetoclax in Newly Diagnosed and Relapsed CBF/::MYH11(+) Acute Myeloid Leukemia
    Feng, Ziyu
    Hu, Xiaohui
    Li, Weiyang
    Xu, Ting
    Xu, Yang
    Xue, Shengli
    Qiu, Huiying
    Tang, Xiaowen
    Han, Yue
    Chen, Suning
    Sun, Aining
    Wu, Depei
    Wang, Ying
    BLOOD, 2024, 144 : 4287 - 4288
  • [28] Oral azacitidine maintenance after intensive chemotherapy versus venetoclax and azacitidine: real world outcomes in newly diagnosed acute myeloid leukemia
    Mims, Alice
    Xie, Zhuoer
    Potluri, Ravi
    Rotter, David
    Chevli, Manoj
    Prebet, Thomas
    Gaugler, Lona
    Strocchia, Maria
    Vasconcelos, Alberto
    Sieluk, Jan
    LEUKEMIA & LYMPHOMA, 2025, 66 (03) : 479 - 487
  • [29] Prediction of Volasertib Sensitivity in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax Plus Azacitidine
    Patil, Lokesh
    Gu, Christine J.
    Tognon, Cristina
    Long, Nicola
    Johnson, Kara
    Fischer, Melissa A.
    Ball, Somedeb
    Savona, Michael R.
    Leonardi, Chris
    Wagner, Joseph
    Michelson, Glenn
    Lacher, Markus D.
    BLOOD, 2024, 144 : 5818 - 5819
  • [30] Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia
    Jonas, Brian A.
    Wei, Andrew H.
    Recher, Christian
    DiNardo, Courtney D.
    Jang, Jun-Ho
    Pratz, Keith
    Panayiotidis, Panayiotis
    Montesinos, Pau
    Yeh, Su-Peng
    Ivanov, Vladimir
    Fiedler, Walter
    Yamauchi, Takahiro
    Duan, Yinghui
    Mendes, Wellington
    Potluri, Jalaja
    Tews, Bjorn
    Ofran, Yishai
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) : E299 - E303
12345